Central hypertensive effects of aldosterone

Frontiers in Neuroendocrinology

Volumn 18, Issue 4, 1997, Pages 440-462

  Gómez Sánchez, Elise P ^a  

^a University of Missouri   (United States)

Author keywords

Adrenal regeneration hypertension; Dahl Salt Sensitive rat; Hypertension; Mineralocorticoids; Neurosteroids; Steroids

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; CORTICOSTEROID; CORTICOSTERONE; GLUCOCORTICOID; GLYCYRRHIZIC ACID; HORMONE RECEPTOR BLOCKING AGENT; HORMONE RECEPTOR STIMULATING AGENT; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; OUABAIN; OXPRENOATE POTASSIUM; PRORENONE; UNCLASSIFIED DRUG;

HYPERTENSION; ION TRANSPORT; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SYMPATHETIC TONE;

EID: 0342711273     PISSN: 00913022     EISSN: None     Source Type: Journal    
DOI: 10.1006/frne.1997.0157     Document Type: Article

References (165)

1. Anderson N D, Fanestil D D. Corticoid receptors in rat brain: Evidence for an aldosterone receptor. Endocrinology. 98:1976;676-684.
2. Arriza J L, Simerly R B, Swanson L W, Evans R M. The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron. 1:1988;887-900.
3. Atarashi K, Matsuoka H, Takagi M. Effects of intracerebroventricular infusion of aldosterone on blood pressure and sodium and potassium concentrations in cerebral spinal fluied in rats. Clin Exp Theor Pract. A10:1988;317-322.
4. Azar S T, Melby J C, Griffing G T, Holbrook M, Johnston J O. Antihypertensive effect of 19-acetylenic-deoxycorticosterone in inbred salt-sensitive rats. Am J Hypertens. 5:1992;372-377.
5. Benos D J, Awayda M S, Ismailov I I, Johnson J P. Structure and function of amiloride-sensitive Na+ channels. J Membr Biol. 143:1995;1-18.
6. Berecek K H. Role of central vasopressin in cardiovascular regulation. J Cardiov Pharm. 8:1986;S76-S80.
7. Berecek K H, Bohr D F. Whole body vascular reactivity during the development of deoxycorticosterone acetate hypertension in the pig. Circ Res. 42:1978;764-771.
8. Betz A J. Sodium transport from blood to brain: Inhibition by furosamide and amiloride. J Neurochem. 41:1983;1158-1164.
9. Bohr D F. What makes the pressure go up? A hypothesis. Hypertension. 3:1981;II-160-II-165.
10. Bohus B, De Kloet E R. Adrenal steroids and extinction behavior: Antagonism by progesterone, deoxycorticosterone and dexamethasone of a specific effect of corticosterone. Life Sci. 28:1980;433-440.
11. Brilla C G, Guarda E, Zhou G, Myers P R, Weber K T. Angiotensin II-mediated aldosterone synthesis in aortic endothelial cells. Circulation. 86:1992;I-90.
12. Brilla C G, Matsubara L S, Weber K T. Antifibrotic Effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. Am J Cardiol. 71:1993;12A-16A.
13. Brody M J, Fink G D, Buggy J, Haywood J R, Gordon F J, Johnson A K. The role of the anteroventral third ventrical (AV3V) region in experimental hypertension. Circ Res. 43:1978;2-13.
14. Brody M J, Haywood J R, Touw K B. Neural mechanisms in hypertension. Annu Rev Physiol. 42:1978;441-453.
15. Brody M J, Varner K J, Vasquez E C, Lewis S J. Central nervous system and the pathogenesis of hypertension. Hypertension. 18:1991;III-7-III-12.
16. Brown R W, Chapman K E, Edwards C RW, Seckl J R. Human placental 11β-hydroxysteroid dehydrogenase: Evidence for and partial purification of a distinct NAD-dependent isoform. Endocrinology. 132:1993;2614-2621.
17. Bruner C A, Mangiapane M L, Fink G D, Webb R C. Area postrema ablation and vascular reactivity in deoxycorticosterone-salt-treated rats. Hypertension. 11:1988;668-673.
18. Bubien J K, Warnock D G. Amiloride-sensitive sodium conductance in human B lymphoid cells. Am Physiol Soc. 265:1993;C1175-c1183.
19. Buckingham J C, Hodges J R. Interrelationships of pituitary and plasma corticosterone during adrenocortical regeneration in the rat. J Endocrinol. 67:1975;411-417.
20. Campbell S E, Janicki J S, Matsubara B B, Weber K T. Myocardial fibrosis in the rat with mineralocorticoid excess, prevention of scarring by amiloride. Am J Hypertens. 6:1993;487-495.
21. Canessa C M, Merillat A M, Rossier B C. Membrane topology of the epithelial sodium channel in intact cells. Am J Physiol. 267:1994;C1682-C1690.
22. Canessa C M, Schild L, Buell G. Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. Nature. 367:1994;463-466.
23. +. EMBO J. 13:1994;2177-2181.
24. Christ M, Douwes K, Eisen C, Bechtner G, Theisen K, Wehling M. Rapid effects of aldosterone on sodium transport in vascular smooth muscle cells. Hypertension. 25:1995;117-123.
25. Coirini H, Marusic E T, De Nicola A F, Rianbow T C, McEwen B S. Identification of mineralocorticoid binding sites in rat brain by competition studies and density gradient centrifugation. Neuroendocrinology. 37:1983;354-360.
26. Compagnone N A, Bulfone A, Rubenstein J LR, Mellon S H. Expression of the steroidogenic enzyme P450scc in the central and peripheral nervous sustem during rodent embryogenesis. Endocrinology. 136:1995;2689-2696.
27. Cover C M, Wang J, St Lezin E, Kurtz T W, Mellon S H. Molecular variants in the P450c11AS gene as determinants of aldosterone synthase activity in the Dahl Rat Model of Hypertension. J Biol Chem. 270:1995;16555-16560.
28. Dahl L K, Heine M, Tassinari L. Effects of chronic excess salt ingestion: Evidence that genetic factors play an important role in susceptibility to experimental hypertension. J Exp Med. 115:1963;1173-1190.
29. De Kloet E R. Brain corticosteroid receptor balance and homeostatic control. Fron Neuroendocrinol. 12:1991;95-164.
30. De Kloet E R, Ratka A, Reul J, Sutanto W, Van Eekelen J AM. Corticosteroid receptor types in brain: regulation and putative function. Ann NY Acad Sci. 512:1987;351-361.
31. De Kloet E R, Sybesma H, Reul H M. Selective control by corticosterone of serotonin 1 receptor capacity in raphe-hippocampal system. Neuroendocrinology. 42:1986;513-521.
32. De Kloet E R, Versteeg D HG, Kovacs G L. Aldosterone blocks the response to corticosterone in the raphe-hippocampal serotonin system. Brain Res. 264:1983;323-327.
33. de Wardener H E. Kidney, salt intake, and Na+,K+-ATPase inhibitors in hypertension. Hypertension. 17:1991;830-835.
34. Denton D A, McKinley M J, Weisinger R S. Hypothalamic integration of body fluid regulation. Proc Natl Acad Sci USA. 93:1996;7397-7404.
35. Doyle D, Smith R, Krozowski Z S, Funder J W. Mineralocorticoid specificity of renal type I receptors: Binding and metabolism of corticosterone. J Steroid Biochem. 33:1989;165-170.
36. Duc C, Farman N, Canessa C M, Bonvalet J-P, Rossier B C. Cell-specific expression of epithelial sodium channel a, b, and g subunits in aldosterone-responsive epithelia from the rat: Localization by in situ hybridization and immunocytochemistry. J Cell Biol. 127:1994;1907-1921.
37. Edwards C. The selectivity of ion channels in nerve and muscle. Neuroscience. 7:1982;1335-1366.
38. Edwards C RW, Benediktsson R, Lindsay R S, Seckl J R. Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension. Lancet. 341:1993;355-357.
39. Edwards C RW, Burt D, McIntyre M A. Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet. ii:1988;986-989.
40. Edwards C RW, Stewart P M. The cortisol-cortisone shuttle and the apparent specificity of glucocorticoid and mineralocorticoid receptors. J Steroid Biochem Mol Biol. 39:1991;859-865.
41. Erdmann B, Gerst H, Lippoldt A. Expression of cytochrome P45011B1 mRNA in the brain of normal and hypertensive transgenic rats. Brain Res. 733:1996;73-82.
42. Ferrandi M, Minotti E, Salardi S, Florio M, Bianchi G, Ferrari P. Ouabainlike factor in Milan hypertensive rats. Am J Physiol. 263:1992;F739-F748.
43. Ferrario C M, Moharra O, Ueno Y, Brosnihan K B. Hemodynamic and neurohormonal changes in the development of DOC hypertension in the dog. Am J Med Sci. 295:1988;352-359.
44. Foulkes R, Gardiner S M, Bennett T. Adrenal regeneration hypertension in the rat. J Hypertens. 5:1987;637-644.
45. Funder J, Myles K. Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action:In vivo. Endocrinology. 137:1996;5264-5268.
46. Funder J W. How can aldosterone act as a mineralocorticoid? Endocr Res. 15:1989;227-238.
47. Funder J W. Mineralocorticoids, glucocorticoids, receptors and response elements. Science. 259:1993;1132-1133.
48. Funder J W, Feldman D, Edelman I S. Glucocorticoid receptors in rat kidney: The binding of tritiated-dexamethasone. Endocrinology. 92:1973;1005-1013.
49. Funder J W, Feldman D, Edelman I S. Specific Aldosterone binding in rat kidney and parotid. J Steroid Biochem. 3:1972;209-218.
50. Funder J W, Pearce P T, Smith R, Smith A I. Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated. Science. 242:1988;583-585.
51. Gadallah M F, Abreo K, Work J. Liddle's syndrome, an underrecognized entity: A report of four cases, including the first report in black individuals [see comments]. Am J Kid Dis. 25:1995;829-835.
52. Gallant S, Brownie A C. Peripheral levels of corticosterone, 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone during the development of adrenal regeneration hypertension. Life Sci. 24:1979;1097.
53. +. FASEB J. 8:1994;522-528.
54. Garwitz E T, Jones A W. Altered arterial ion transport and its reversal in aldosterone hypertensive rat. Am J Physiol. 243:1982;H927-H933.
55. Gavras H, Gavras I. Salt-induced hypertension: The interactive role of vasopressin and of the sympathetic nervous system. J Hypertens. 7:1989;601-606.
56. Gomez-Sanchez C E, Gomez-Sanchez E P, Upcavage R J, Hall E B. Urinary free and serum 19-nor-deoxycorticosterone in adrenal regeneration hypertension. Hypertension. 5:1983;I-32-I-34.
57. Gomez-Sanchez C E, Holland O B, Murry B A. Mineralocorticoid radioreceptor assay: Application to adrenal-regeneration hypertension. Life Sci. 21:1977;989-996.
58. Gomez-Sanchez C E, Holland O B, Murry B A, Lloyd H, Milewich L. 19-nor-deoxycorticosterone: A potent mineralocorticoid isolated from the urine of rats with regenerating adrenals. Endocrinology. 105:1979;708-711.
59. Gomez-Sanchez C E, Morris D J. Other mineralocorticoids and glucocorticoids. Hypertension Primer. 1993;American Heart Association, Dallas. p. 20-21.
60. Gomez-Sanchez C E, Zhou M Y, Cozza E N, Morita H, Eddleman F C, Gomez-Sanchez E P. Corticosteroid synthesis in the central nervous system. Endocr Res. 22:1996;463-470.
61. Gomez-Sanchez C E, Zhou M Y, Cozza E N, Morita H, Foecking M F, Gomez-Sanchez E P. Aldosterone biosynthesis in the rat brain. Endocrinology. 138:1997;3369-3373.
62. Gomez-Sanchez E P. Intracerebroventricular infusion of aldosterone induces hypertension in rats. Endocrinology. 118:1986;819-823.
63. Gomez-Sanchez E P. Dose-response studies of intracerebroventricular infusion of aldosterone in sensitized and nonsensitized rats. J Hypertension. 6:1988;437-442.
64. Gomez-Sanchez E P. Adrenocorticosteroids and cardiovascular regulation: Methods for surgery and blood pressure measurements. De Kloet E R, Sutanto W. Methods in Neurosciences: Neurobiology of Steroids. 1994;496-509 Academic Press, Inc, Orlando.
65. Gomez-Sanchez E P. Mineralocorticoid modulation of central control of blood pressure. Steroids. 60:1995;69-72.
66. Gomez-Sanchez E P, Fort C, Thwaites D. Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S/JR rats. Am J Physiol. 262:1992;E96-E99.
67. Gomez-Sanchez E P, Fort C M, Gomez-Sanchez C E. Intracerebroventricular infusions of RU28318 blocks aldosterone-salt hypertension. Am J Physiol. 258:1990;E482-E484.
68. Gomez-Sanchez E P, Gomez-Sanchez C E. Effect of central amiloride infusion on mineralocorticoid hypertension. Am J Physiol. 267:1994;E754-E758.
69. Gomez-Sanchez E P, Gomez-Sanchez C E. The effect of the central infusion of benzamil on Dahl S rat hypertension. Am J Physiol. 269:1995;H1044-H1047.
70. Gomez-Sanchez E P, Gomez-Sanchez C E, Fort C. Immunization of Dahl SS/jr rats with a ouabain conjugate mitigates salt-induced hypertension. Am J Hypertens. 7:1994;591-596.
71. Gomez-Sanchez E P, Venkataraman M T, Thwaites D. ICV infusion of Corticosterone antagonizes ICV-aldosterone hypertension. Am J Physiol. 258:1990;E649-E653.
72. Gomez-Sanchez E P, Zhou M Y, Gomez-Sanchez C E. Mineralocorticoids, salt and high blood pressure: Causes. Steroids. 61:1996;184-188.
73. Grosser B I. 11β-Hydroxysteroid metabolism by mouse brain and glioma 261. J Neurochem. 13:1966;475-478.
74. Guthrie G P. Mineralocorticoid and endocrine effects of chewing tobacco use. Proc 75th Endocr Soc. 1993;966.
75. Haeusler G, Finch L, Thoenen L. Central adrenergic neurons and the initiation and development of experimental hypertension. Experientia. 28:1972;1200-1203.
76. Hansson J H, Nelson-Williams C, Suzuki H. Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nature Genet. 11:1995;76-82.
77. ++. J Clin Hypertens. 3:1987;419-429.
78. Hatakeyama H, Miyamori I, Fujita T, Takeda Y, Takeda R, Yamamoto H. Vascular Aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem. 269:1994;24316-24320.
79. Hu Z Y, Bourreau E, Jung-Testas I, Robel P, Baulieu E. Neurosteroids: Oligodendrocyte mitochondria convert cholesterol to pregnenolone. Proc Natl Acad Sci USA. 84:1987;8215-8219.
80. Huang B S, Huang X, Harmsen E, Leenen F HH. Chronic central versus peripheral ouabain, blood pressure and sympathetic activity in rats. Hypertension. 23:1994;1087-1090.
81. Huang B S, Leenen F H. Brain 'ouabain' and desensitization of arterial baroreflex by high sodium in Dahl salt-sensitive rats. Hypertension. 25:1995;372-376.
82. Huang B S, Leenen F HH. Brain "ouabain" mediates the sympathoexcitatory and hypertensive effects of high sodium intake in Dahl Salt-sensitive rats. Circ Res. 74:1994;586-595.
83. 21. J Steroid Biochem Mol Biol. 44:1993;163-169.
84. Janiak P, Brody M J. Central interactions between aldosterone and vasopressin on cardiovascular system. Am J Physiol. 255:1988;R166-R173.
85. Janiak P C, Brody M J. Central interactions between aldosterone and vasopressin on cardiovascular system. Am J Physiol. 24:1988;R166-R173.
86. Janiak P C, Lewis S J, Brody M J. Role of central mineralocorticoid binding sites in development of hypertension. Am J Physiol. 259:1990;R1025-R1034.
87. Jellinck P H, Monder C, McEwen B S, Sakai R R. Differential inhibition of 11β-hydroxysteroid dehydrogenase by carbenoxolone in rat brain regions and peripheral tissues. J Steroid Biochem Mol Biol. 46:1993;209-213.
88. Jo H, Yang E K, Lee W J, Park K Y, Kim H J, Park J S. Gene expression of central and peripheral renin-angiotensin system components upon dietary sodium intake in rats. Regul Pept. 67:1996;115-121.
89. Joels M, De Kloet E R. Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems. Prog Neurobiol. 43:1994;1-36.
90. Johnson A K. Vasopressin. 1995;Raven Press, New York. p. 319-331.
91. Johnson A K, Cunningham J T, Thunhorst R L. Integrative role of the lamina terminalis in the regulation of cardiovascular and body fluid homeostasis. Clin Exp Pharmacol Physiol. 23:1996;183-191.
92. Johnston J O, Wright C L, Holbert G W. Enzyme activated inhibitors of steroid hydroxylases. J Steroid Biochem Mol Biol. 52:1995;17-34.
93. Kageyama Y, Bravo E L. Hypertensive mechanisms associated with centrally administered aldosterone in dogs. Hypertension. 11:1988;750-753.
94. Kenyon C J, Saccoccio N A, Morris D J. Glucocorticoid inhibition of mineralocorticoid action in the rat. Clin Sci. 67:1984;239-335.
95. Koenig H L, Schumacher M, Ferzaz B. Progesterone synthesis and myelin formation by Schwann cells. Science. 268:1995;1500-1503.
96. Kramer H J, Meyer-Lehnert H, Michel H, Predel H-G. Endogenous natriuretic and ouabain-like factor: Their roles in body fluid volume and blood pressure regulation. Am J Hypertens. 4:1991;81-89.
97. Krozowski Z S, Funder J W. Renal mineralocorticoid receptors and hippocampal corticosterone binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci USA. 80:1983;6056-6060.
98. Kubo T, Hashimoto M. Effects of intraventricular and intraspinal 6-hyroxydopamine and blood pressure of DOCA-saline hypertensive rats. Arch Int Pharmacodyn. 238:1979;50-59.
99. Kuhlman D, Ragan C, Ferrebee J W, Atchley D W, Loeb R F. Toxic effects of deoxycorticosterone esters in dogs. Science. 90:1939;496-497.
100. Lakshmi V, Sakai R R, McEwen B S, Monder C. Regional distribution of 11β-hydroxysteroid dehydrogenase in rat brain. Endocrinology. 128:1991;1741-1748.
101. Le Goascogne C, Robel P, Gouézou M, Sananes N, Baulieu E, Waterman M. Neurosteroids: Cytochrome P-450scc in Rat Brain. Science. 237:1987;1212-1215.
102. +. J Biol Chem. 269:1994;13736-13739.
103. Marver D. Models of aldosterone action on sodium transport: Emerging concepts. Adv Exp Med Biol. 196:1986;153-171.
104. Masugi F, Ogihara T, Hasegawa T, Kumahara Y. Ouabain-like and non-ouabain-like factors in plasma of patients with essential hypertension. Clin Exp Theor Pract. A9:1987;1233-1242.
105. Masugi F, Ogihara T, Hasegawa T. Circulating factor with ouabain-like immunoreactivity in patients with primary aldosteronism. Biochem Biophys Res Commun. 135:1986;41-45.
106. Matsuguchi H, Sharabi F M, O'Connor G, Mark A L, Schmid P G. Central mechanisms in DOC-hypertensive rats. Clin Exp Hypertens. A4:1982;1303-1321.
107. +. Am J Physiol. 266:1994;L728-L734.
108. McEwen B S, Lambdin L T, Rainbow T C, De Nicola A F. Aldosterone effects on salt appetite in adrenalectomized rats. Neuroendocrinology. 43:1986;38-43.
109. McKinley M J, Pennington G L, Oldfield B J. Anteroventral wall of the third ventricle and dorsal lamina terminalis-headquarters for control of body fluid homeostasis. Clin Exp Pharmacol Physiol. 23:1996;271-281.
110. Mellon S H, Deschepper C F. Neurosteroid biosynthesis: Genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Res. 629:1993;283-292.
111. Moisan M P, Seckl J R, Edwards C RW. 11β-Hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: Localization in hypothalamus, hippocampus, and cortex. Endocrinology. 127:1990;1450-1455.
112. Mune T, Rogerson F M, Nikkilä H, Agarwal A K, White P C. Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase. Nature Genet. 10:1995;394-399.
113. Nakamoto H, Suzuki H, Kageyama Y, Murakami M, Naitoh M, Saruta T. Central nervous system mediates an antihypertensive property in glucocorticoid hypertension in dogs. J Hypertens. 13:1995;1169-1179.
114. Nakata T, Takeda K, Itho H. Paraventricular nucleus lesions attenuate the development of hypertension in DOCA/salt-treated rats. Am J Hypertens. 2:1989;625-630.
115. 11b. J Neurosci Res. 28:1991;518-524.
116. Paul S M, Purdy R H. Neuroactive steroids. FASEB J. 6:1992;2311-2322.
117. Pavlides C, Ogawa S, Kimura A, McEwen B S. Role of adrenal steroid mineralocorticoid and glucocorticoid receptors in long-term potentiation in the CA1 field of hippocampal slices. Brain Res. 738:1996;229-235.
118. Pearce D. A mechanistic basis for distinct mineralocorticoid and glucocorticoid receptor transcriptional specificities. Steroids. 59:1994;153-159.
119. Pearce D, Yamamoto K R. Mineralocorticoid and glucocorticoid receptor activities distinguised by nonreceptor factors at a composite response element. Science. 259:1993;1161-1165.
120. Peterson N A, Chaikoff I L, Jones C. Thein vitro. J Neurochem. 12:1965;273-278.
121. Peysner K, Henry C A, Malvin R L. Central infusion of aldosterone increases blood pressure by mechanism independent of Na retention. Clin Exp Hypertens. A12:1990;399-414.
122. Rapp J P. Characteristics of Dahl salt-susceptible and salt-resistant rats. de Jong W. Handbook of Hypertension: Experimental and Genetic Models of Hypertension. 1984;286-295 Elsevier, Amsterdam/New York/Oxford.
123. Rapp J P. Dissecting the primary causes of genetic hypertension in rats. Hypertension. 18:1991;I-18-I-28.
124. Rapp J P, Dene H. Development and characteristics of inbred strains of Dahl Salt-sensitive and salt-resistant rats. Hypertension. 7:1985;340-349.
125. Rapp J P, Wang S M, Dene H. Effect of genetic background on cosegragation of renin alleles and blood pressure in Dahl rats. Am J Hypertens. 3:1990;391-396.
126. Reid J L, Zivin J A, Kovin I F. Central and peripheral adrenergic mechanisms in the development of deoxycorticosterone-saline hypertension in rats. Circ Res. 37:1975;569-579.
127. +. J Biol Chem. 269:1994;12981-12986.
128. Reul J MH, De Kloet E R. Two receptor systems for coticosterone in rat brain: Microdistribution and differential occupation. Endocrinology. 117:1985;2505-2511.
129. Ritche J M, Black J A, Waxman S J, Angelides K J. Sodium channels in the cytoplasm of Schwann cells. Proc Natl Acad Sci USA. 87:1990;9290-9294.
130. Roland B L, Li K XZ, Funder J W. Hybridization histochemical localization of 11β-hydroxysteroid dehydrogenase type 2 in rat brain. Endocrinology. 136:1995;4697-4700.
131. Rossier B C, Canessa C M, Schild L S, Horisberger J-D. Epithelial sodium channels. Curr Opin Neph Hyper. 3:1994;487-496.
132. +. EMBO J. 13:1994;4440-4450.
133. Sakai R R, Ma L Y, Zhang D M, McEwen B S, Fluharty S J. Intracerebral administration of mineralocorticoid receptor antisense oligonucleotides attenuate adrenal steroid-induced salt appetite in rats. Neuroendocrinology. 64:1996;425-429.
134. Sakai R R, Nicolaidis S, Epstein A N. Salt appetite is suppressed by interference with angiotensin II and aldosterone. Am J Physiol. 251:1986;R762-R768.
135. Sato A, Funder J W. High glucose stimulates aldosterone-induced hypertrophy via type I mineralocorticoid receptors in neonatal rat cardiomyocytes. Endocrinology. 137:1996;4145-4153.
136. Scoggins B, Kingsley J A, Coghlan J P. Onset and does relationships of ACTH effects on blood pressure in sheep. Hypertension. 7:1985;287-291.
137. Seckl J R, Dow R C, Low S C, Edwards C RW, Fink G. The 11β-hydroxysteroid dehydrogenase inhibitor glycyrrhetinic acid affects corticosteroid feedback regulation of hypothalamic corticotrophin-releasing peptides in rats. J Endocrinol. 136:1993;471-477.
138. Sekihara H, Yazaki Y, Kojima T. Ouabain as an amplifier of mineralocorticoid-induced hypertension. Endocrinology. 131:1992;3077-3082.
139. Selye H. The anesthetic effect of steroid hormones. Proc Soc Exp Biol Med. 46:1941;116-121.
140. Shackleton C HL, Arteaga J RE, Lopez J M, Winter J SD. Congenital 11β-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: Corticosteroid metabolite profiles of four patients and their families. Clin Endocrinol. 22:1985;701-712.
141. Shimkets R A, Warnock D G, Bositis C M. Liddle's syndrome: Heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell. 79:1994;407-414.
142. Skelton F R. Development of hypertension and cardiovascular renal lesions during adrenal regeneration in the rat. Proc Soc Exp Biol Med. 90:1955;342-346.
143. Smith P R, Saccomani G, Joe E-H, Angelides K J, Benos D J. Amiloride-sensitive sodium channel is linked to the cytoskeleton in renal epithelial cells. Proc Natl Acad Sci USA. 88:1991;6971-6975.
144. Smith R E, Mercer W R, Provencher P H, Obeyesekere V, Krozowski Z S. The heterogeneity of 11β-hydroxysteroid dehydrogenase activities in the rat hippocampus implies a complex regulation of steroid hormone action. Clin Exp Pharmacol Physiol. 19:1992;365-368.
145. Souness G W, Morris D J. 11α- and 11β-Hydroxyprogesterone, potent inhibitors of 11b-hydroxysteroid dehydrogenase, possess hypertensinogenic activity in the rat. Hypertension. 27:1996;421-425.
146. +. EMBO J. 15:1996;2371-2380.
147. Stumpf W E, Sar M. Glucocorticosteroids and mineralocorticosteroid hormone target sites in the brain. Autoradiographic studies with corticosterone, aldosterone, deoxycorticosterone: Jones M T, Dallman M F, Gillham B, Chattopadhyay S. Interaction within the Brain-Pituitary-Adrenocortical System. 1979;137-147 Academic Press, San Diego.
148. Takeda K, Nakamura Y, Hayashi J. Effects of Salt and DOCA on hypothalamic and baroreflex control of blood pressure. Clin Exp Hypertens. A10:1988;289-299.
149. Takeda R, Hatakeyama H, Takeda Y. Aldosterone biosynthesis and action in vascular cells. Steroids. 60:1995;120-124.
150. Tonolo G, Soro A, Madeddu P. Effect of chronic intracerebroventricular dexamethasone on blood pressure in normotensive rats. Am J Physiol. 264:1993;E843-E847.
151. Tramposch A F, Lopes O U, Chernicky C L, Ferrario C M. Alternative mechanism for attenuated pressor responses in AV3V-lesioned dogs. Am J Physiol. 257:1989;R431-R438.
152. Tresham J J, Coghlan J P, May C N. Evidence against a central pressor mechanism for adrenocortical steroid hypertension in sheep. Clin Exp Hypertens. 18:1996;831-849.
153. Ulick S, Tedde R, Wang J Z. Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab. 74:1992;593-599.
154. van den Berg D TWM, De Kloet E R, de Jong W. Central effects of mineralocorticoid antagonist RU-28318 on blood pressure of DOCA-salt hypertensive rats. Am J Physiol. 267:1994;E927-E933.
155. van den Berg D TWM, De Kloet E R, van Dijken H H, de Jong W. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure. Endocrinology. 126:1990;118-124.
156. Vigne P, Champigny G, Marsault R, Barbry P, Frelin C, Lazdunski M. A new type of amiloride-sensitive cationic channel in endothelial cells of brain microvessels. J Biol Chem. 264:1988;7663-7668.
157. Waldmann R, Champigny G, Bassilana F, Voilley N, Lazdunski M. Molecular cloning and functional expression of a novel amiloride-sensitive Na+ channel. J Biol Chem. 270:1995;27411-27414.
158. Wehling M, Eisen C, Christ M. Aldosterone-specific membrane receptors and rapid non-genomic actions of mineralocorticoids. Mol Cell Endocrinol. 90:1992;C5-C9.
159. 2+. Circ Res. 76:1995;973-979.
160. Wehling M, Ulsenheimer A, Schneider M, Neylon C, Christ M. Rapid effects on free intracellular calcium in vascular smooth muscle and endothelial cells: Subcellular localization of calcium elevations by single cell imaging. Biochem Biophys Res Commun. 204:1994;475-481.
161. Wohlfeil S, Neuser D, Morich F J. Biosynthesis of 18-hydroxydeoxycoticosterone and corticosterone in adrenal tissue of rat strains with salt-dependent hypertension. Clin Exp Hypertens Theory Pract. A10:1988;617-627.
162. Wrange O, Yu Z-Y. Mineralocorticoid receptor in rat kidney and hippocampus: Characterization and quantitation by isoelectric focusing. Endocrinology. 113:1983;243-250.
163. Yongue B G, Roy E J. Endogenous aldosterone and corticosterone in brain cell nuclei of adrenal-intact rats: Regional distribution and effects of physiological variations in serum steroids. Brain Res. 436:1987;49-61.
164. Young M, Head G, Funder J. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am J Physiol. 269:1995;E657-E662.
165. Zhou M Y, Gomez-Sanchez E P, Cox D L, Cosby D, Gomez-Sanchez C E. Cloning, expression and tissue distribution of the rat NAD+-dependent 11β-hydroxysteroid dehydrogenase. Endocrinology. 136:1995;3729-3734.